
|Articles|May 17, 2004
P&T Portfolio: Avastin
Bevacizumab (Avastin) for intravenous use in patients with metastatic colorectal cancer.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Measles Cases Surpass 2000 in 2026, Threatening US Elimination Status
2
Naloxone Access Continuously Improves as Gaps Persist in Pharmacy
3
Same-Day COVID-19, Influenza Vaccination Does Not Increase Adverse Events
4
Study Finds No Link Between Prenatal Acetaminophen Use and Autism, ADHD
5

































